GALECTIN THERAPEUTICS INC (GALT) Net Cash Provided by (Used in) Financing Activities USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Galectin Therapeutics Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2024.
  • Galectin Therapeutics Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $10 M, unchanged year-over-year.
  • Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $40 M, a 300% increase from 2022.
  • Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $10 M, a 72.8% decline from 2021.
  • Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $36.8 M, a 13898% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $10 M $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $10 M +$10 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $0 -$219 K -100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $219 K -$1.78 M -89.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $2 M -$2.45 M -55% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $4.45 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2014 $30.1 M +$30 M +39022% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-13
Q1 2013 $77 K -$10.3 M -99.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q1 2012 $10.4 M +$7.98 M +329% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 $2.42 M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.